Use of Automatic Relevance Determination in QSAR Studies Using Bayesian Neural Networks

We describe the use of Bayesian regularized artificial neural networks (BRANNs) coupled with automatic relevance determination (ARD) in the development of quantitative structure-activity relationship (QSAR) models. These BRANN-ARD networks have the potential to solve a number of problems which arise in QSAR modeling such as the following: choice of model; robustness of model; choice of validation set; size of validation effort; and optimization of network architecture. The ARD method ensures that irrelevant or highly correlated indices used in the modeling are neglected as well as showing which are the most important variables in modeling the activity data. The application of the methods to QSAR of compounds active at the benzodiazepine and muscarinic receptors as well as some toxicological data of the effect of substituted benzenes on Tetetrahymena pyriformis is illustrated.

[1]  F. Burden.  Using Artificial Neural Networks to Predict Biological Activity from Simple Molecular Structural Considerations , 1996 .

[2]  Alexander Tropsha,et al.  Novel Variable Selection Quantitative Structure-Property Relationship Approach Based on the k-Nearest-Neighbor Principle , 2000, J. Chem. Inf. Comput. Sci..

[3]  S. J. Ireland,et al.  Syntheses, pharmacological evaluation and molecular modelling of substituted 6-alkoxyimidazo[1,2-b]pyridazines as new ligands for the benzodiazepine receptor , 1996 .

[4]  J S Ward,et al.  Novel functional M1 selective muscarinic agonists. 2. Synthesis and structure-activity relationships of 3-pyrazinyl-1,2,5,6-tetrahydro-1-methylpyridines. Construction of a molecular model for the M1 pharmacophore. , 1992, Journal of medicinal chemistry.

[5]  F. Burden,et al.  Robust QSAR models using Bayesian regularized neural networks. , 1999, Journal of medicinal chemistry.

[6]  Igor V. Tetko,et al.  Neural Network Studies, 2. Variable Selection , 1996, J. Chem. Inf. Comput. Sci..

[7]  Desire L. Massart,et al.  Random correlation in variable selection for multivariate calibration with a genetic algorithm , 1996 .

[8]  Ravinder Nath,et al.  Determining the saliency of input variables in neural network classifiers , 1997, Comput. Oper. Res..

[9]  G Bolliger,et al.  Muscarinic activity of the thiolactone, lactam, lactol, and thiolactol analogues of pilocarpine and a hypothetical model for the binding of agonists to the m1 receptor. , 1992, Journal of medicinal chemistry.

[10]  P. W. Codding,et al.  Synthesis of novel 3-substituted beta-carbolines as benzodiazepine receptor ligands: probing the benzodiazepine receptor pharmacophore. , 1988, Journal of medicinal chemistry.

[11]  T. Langer,et al.  Computer-aided molecular modeling, synthesis, and biological evaluation of 8-(benzyloxy)-2-phenylpyrazolo[4,3-c]quinoline as a novel benzodiazepine receptor agonist ligand. , 1995, Journal of medicinal chemistry.

[12]  P. Skolnick,et al.  Structural requirements for agonist actions at the benzodiazepine receptor: studies with analogues of 6-(benzyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester. , 1990, Journal of medicinal chemistry.

[13]  Roberto Todeschini,et al.  Kohonen artificial neural networks as a tool for wavelength selection in multicomponent spectrofluorimetric PLS modelling: application to phenol, o-cresol, m-cresol and p-cresol mixtures , 1999 .

[14]  T W Schultz,et al.  Quantitative structure-activity analyses of nitrobenzene toxicity to Tetrahymena pyriformis. , 1998, Chemical research in toxicology.

[15]  L. P. Davies,et al.  Substituted imidazo[1,2-b]pyridazines. New compounds with activity at central and peripheral benzodiazepine receptors. , 1992, Biochemical pharmacology.

[16]  N Yokoyama,et al.  2-Arylpyrazolo[4,3-c]quinolin-3-ones: novel agonist, partial agonist, and antagonist of benzodiazepines. , 1982, Journal of medicinal chemistry.

[17]  Mark T. D. Cronin,et al.  QSAR STUDY OF THE TOXICITY OF NITROBENZENES TO TETRAHYMENA PYRIFORMIS , 1995 .

[18]  Frank R. Burden,et al.  Atomistic topological indices applied to benzodiazepines using various regression methods , 1998 .

[19]  F E Blaney,et al.  Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptor. , 1991, Journal of medicinal chemistry.

[20]  M. Randic.  Characterization of molecular branching , 1975 .

[21]  C. Hansch,et al.  p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure , 1964 .

[22]  T W Schultz,et al.  Quantitative structure-activity study of the toxicity of benzonitriles to the ciliate Tetrahymena pyriformis. , 1995, SAR and QSAR in environmental research.

[23]  Chris L. Waller,et al.  Development and Validation of a Novel Variable Selection Technique with Application to Multidimensional Quantitative Structure-Activity Relationship Studies , 1999, J. Chem. Inf. Comput. Sci..

[24]  S. Bromidge,et al.  Substituent variation in azabicyclic triazole- and tetrazole-based muscarinic receptor ligands. , 1992, Journal of medicinal chemistry.

[25]  Rohan Andrew Davis,et al.  Imidazo[1,2-b]pyridazines. XVII. Synthesis and Central Nervous System Activity of Some 6-(Alkylthio and chloro)-3-(methoxy, unsubstituted and benzamidomethyl)-2-arylimidazo[1,2-b]pyridazines Containing Methoxy, Methylenedioxy and Methyl Substituents , 1994 .

[26]  C. B. Naylor,et al.  Synthesis and muscarinic activities of quinuclidin-3-yltriazole and -tetrazole derivatives. , 1992, Journal of medicinal chemistry.

[27]  K. Funatsu,et al.  GA strategy for variable selection in QSAR studies: GAPLS and D-optimal designs for predictive QSAR model , 1998 .

[28]  P. Skolnick,et al.  Structure-activity relationship studies at the benzodiazepine receptor (BZR): a comparison of the substitutent effects of pyrazoloquinolinone analogs. , 1993, Journal of medicinal chemistry.

[29]  J S Ward,et al.  Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines . , 1992, Journal of medicinal chemistry.

[30]  T. Honoré,et al.  Muscarinic cholinergic agonists and antagonists of the 3-(3-alkyl-1,2,4-oxadiazol-5-yl)-1,2,5,6-tetrahydropyridine type. Synthesis and structure-activity relationships. , 1991, Journal of medicinal chemistry.

[31]  F. Burden,et al.  A quantitative structure--activity relationships model for the acute toxicity of substituted benzenes to Tetrahymena pyriformis using Bayesian-regularized neural networks. , 2000, Chemical research in toxicology.

[32]  L L Iversen,et al.  Novel quinuclidine-based ligands for the muscarinic cholinergic receptor. , 1990, Journal of medicinal chemistry.